October 30, 2008
Celiac Disease Drug Gets Positive Results
The second drug is ALV003 for which Alvine Pharmaceuticals is conducting trials. Yesterday there was a news update regarding this drug. Here are a couple of brief quotes.
"Alvine Pharmaceuticals, Inc., today announced proof of concept in a Phase
1 Trial of ALV003, an oral protease therapy in development to detoxify gluten,
intended for use by patients with celiac disease."
"Results from these studies support the use of ALV003 as a drug to be taken
with meals to address unintentional gluten exposure."
If you have celiac disease, I suggest you take a minute to read the entire article here:
Alvine Pharmaceuticals Reports Positive Results With ALV003
Labels: celiac disease
Subscribe to Post Comments [Atom]
Links to this post:
Subscribe to Posts [Atom]